ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

APM Aptorum Group Ltd

5.48
-0.08 (-1.44%)
25 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Aptorum Group Ltd APM NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.08 -1.44% 5.48 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.60 5.40 5.6802 5.48 5.56
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/3/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/3/202407:00BWAptorum Group Ltd Announces Entering into an Agreement and..
22/12/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/12/202315:30BWAptorum Group Limited Reports Financial Results and Business..
21/12/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202315:30BWAptorum Group Limited Announces Results of 2023 Annual..
30/11/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202309:25EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
16/11/202310:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202310:00BWAptorum Group Limited to Hold Annual General Meeting of..
11/9/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/8/202305:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/8/202301:57BWAptorum Group Receives Nasdaq Approval to Transfer Listing..
14/7/202315:30EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
30/6/202315:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/6/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/6/202307:00BWAptorum Group Updates on a Phase 1b/2a Clinical Trial for..
09/6/202315:30BWAptorum Group Limited Announces Voluntary Delisting from..
05/5/202315:31BWAptorum Group Receives Nasdaq Notification of Minimum..
01/5/202307:00BWAptorum Therapeutics Limited Enters Into Letter of Intent..
28/4/202308:44BWAptorum Group Limited Reports 2022 Fiscal Year End Financial..

Su Consulta Reciente

Delayed Upgrade Clock